You are here

  • Home
  • Archive
  • Volume 7, Issue 4
  • Person-centred transition programme to empower adolescents with congenital heart disease in the transition to adulthood: a study protocol for a hybrid randomised controlled trial (STEPSTONES project)

Article info

Article menu

Download PDFPDF

XML
Cardiovascular medicine
Protocol
Person-centred transition programme to empower adolescents with congenital heart disease in the transition to adulthood: a study protocol for a hybrid randomised controlled trial (STEPSTONES project)

Authors

  • Mariela Acuña Mora Institute of Health and Care Sciences, University of Gothenburg, Gothenburg, Sweden Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium PubMed articlesGoogle scholar articles
  • Carina Sparud-Lundin Institute of Health and Care Sciences, University of Gothenburg, Gothenburg, Sweden PubMed articlesGoogle scholar articles
  • Ewa-Lena Bratt Institute of Health and Care Sciences, University of Gothenburg, Gothenburg, Sweden Department of Pediatric Cardiology, The Queen Silvia Children's Hospital, Gothenburg, Sweden PubMed articlesGoogle scholar articles
  • Philip Moons Institute of Health and Care Sciences, University of Gothenburg, Gothenburg, Sweden Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Philip Moons; philip.moons{at}kuleuven.be
View Full Text

Citation

Acuña Mora M, Sparud-Lundin C, Bratt E, et al
Person-centred transition programme to empower adolescents with congenital heart disease in the transition to adulthood: a study protocol for a hybrid randomised controlled trial (STEPSTONES project)
BMJ Open 2017;7:e014593. doi: 10.1136/bmjopen-2016-014593

Publication history

  • Received October 5, 2016
  • Revised January 19, 2017
  • Accepted January 23, 2017
  • First published April 17, 2017.
Online issue publication 
February 21, 2019
Previous versions
Review history

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/